RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers.

Abraham, Hannah G; Ulintz, Peter J; Goo, Laura; Yates, Joel A; Little, Andrew C; Bao, Liwei; Wu, Zhifen; Merajver, Sofia D

Abraham, Hannah G; Ulintz, Peter J; Goo, Laura; Yates, Joel A; Little, Andrew C; Bao, Liwei; Wu, Zhifen; Merajver, Sofia D.

Afiliación

Abraham HG; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Ulintz PJ; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Goo L; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Yates JA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Little AC; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Bao L; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Wu Z; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Merajver SD; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.

Front Oncol ; 11: 712041, 2021.

Article en En | MEDLINE | ID: mdl-34513691

Palabras clave

RhoC; TNBC; breast cancer; interferon; junctions

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google